Loading...
In vitro activity of trovafloxacin against Chlamydia pneumoniae.
Journal Title
Antimicrobial agents and chemotherapy
Keywords
Readers/Advisors
Journal Title
Term and Year
Publication Date
1997-09
Book Title
Publication Volume
41
Publication Issue
9
Publication Begin
2033
Publication End
4
Number of pages
Collections
Files
Loading...
aac.41.9.2033.pdf
Adobe PDF, 143.33 KB
Research Projects
Organizational Units
Journal Issue
Abstract
The in vitro susceptibilities of 12 strains of Chlamydia pneumoniae to a new quinolone, trovafloxacin, and ofloxacin, doxycycline, erythromycin, and azithromycin were determined. The activity of trovafloxacin was similar to that of ofloxacin, with a MIC at which 90% of the isolates are inhibited and a minimal concentration at which 90% of the isolates are killed of 1.0 microg/ml, but trovafloxacin was less active than doxycycline, erythromycin, and azithromycin.
Citation
Roblin PM, Kutlin A, Hammerschlag MR. In vitro activity of trovafloxacin against Chlamydia pneumoniae. Antimicrob Agents Chemother. 1997 Sep;41(9):2033-4. doi: 10.1128/AAC.41.9.2033. PMID: 9303410; PMCID: PMC164061.
